Transgene News and Activities

Transgene is owned by Institut Merieux. Institut Merieux has a direct presence in 2 countries.

Institut Merieux has 6 subsidiaries including Advanced BioScience Laboratories, BioMerieux and BioMerieux Americas.

They are in:

• Healthcare43%
• Pharmaceuticals29%
• Other29%

View the org chart displaying its 28 main executives

Most searched biographies at Transgene

• Alessandro Riva, Chairman of the Board and Chief Executive Officer
• Maya Said, Director
• Marie Landel, Director

Create your alert
to follow the executive moves at Transgene.

Institut Merieux has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Transgene

• Terms of Use – Transgene
• PME des biotechnologies : comment poursuivre votre développement ? | Euronewseuronews_icons_loading

Social media about Transgene

• Transgene on Wikipedia, Google News & Yahoo Finance
• Transgene on LinkedIn, X (Twitter) & YouTube